Redhill Biopharma
RDHL
14 hedge funds and large institutions have $51.2K invested in Redhill Biopharma in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
35% more capital invested
Capital invested by funds: $37.9K → $51.2K (+$13.3K)
17% more funds holding
Funds holding: 12 → 14 (+2)
0.4% less ownership
Funds ownership: 1.1% → 0.71% (-0.4%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$29K |
| 2 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$62 |
| 3 |
YAL
Your Advocates Ltd
Houston,
Texas
|
+$31 |
| 4 |
RIL
Rothschild Investment LLC
Chicago,
Illinois
|
+$28 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
-$3.17K |
| 3 |
GI
GAMMA Investing
Foster City,
California
|
-$3.14K |
| 4 |
Morgan Stanley
New York
|
-$2.93K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$396 |
RDHL Hedge Fund Activity: Q3 2025 in Review
14 institutional investors reported a position in Redhill Biopharma (RDHL) for Q3 2025, worth a combined $51.2K — up 35% from $37.9K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RDHL positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Gagnon Securities, opening a new position worth an estimated $29K. The largest seller was UBS Group, cutting an estimated $13K.
- 14 institutional investors held Redhill Biopharma (RDHL) as of Q3 2025, up from 12 in Q2 2025.
- Funds reported $51.2K of Redhill Biopharma stock for Q3 2025, up 35% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q3 2025 and 2 closed out, a net change of +2 holders.
- The largest Redhill Biopharma buyer in Q3 2025 was Gagnon Securities, an estimated $29K added.
- The largest Redhill Biopharma seller in Q3 2025 was UBS Group, an estimated $13K sold.
Based on aggregated 13F filings for Q3 2025.